This inventor holds 1 USPTO granted patent. Top assignee: Cis Bio International. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Yves Frangin: Innovator in Dopamine Transporter Detection
Introduction
Yves Frangin hails from Hommes, France, and has made significant contributions to the field of neuroscience through his innovative work in pharmacology. With a keen focus on the development of advanced techniques for medical applications, he holds a notable patent that demonstrates the potential for groundbreaking research in the detection of dopamine transporters.
Latest Patents
Yves Frangin is credited with a patent titled "Tropane derivatives useable in particular for in vivo detection of dopamine transporters." This invention showcases innovative methods for detecting dopamine transporters in living organisms, potentially aiding in the diagnosis and treatment of various neurological conditions.
Career Highlights
Currently associated with Cis Bio International, Yves Frangin has played a vital role in the company’s endeavors to advance medical imaging technologies. His expertise and dedication to research have allowed him to make substantial contributions to the field, particularly in improving the efficacy of detection methods related to neurotransmitter systems.
Collaborations
Throughout his career, Yves Frangin has collaborated with esteemed colleagues, including Laurent Mauclaire and Patrick Emond. These partnerships have fostered a productive research environment, enabling the team to explore innovative solutions and enhance the scientific community’s understanding of neurological functions.
Conclusion
Yves Frangin's innovative spirit and commitment to advancing neurological research through his patent showcase the power of collaboration and ingenuity in the scientific field. As he continues to work with Cis Bio International and his talented coworkers, the potential for further groundbreaking discoveries remains promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
